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25. Viral infection in children with bronchiectases 
J. PERADZYNSKA, D. CHMIELEWSKA-SZEWCZYK, J. ZIO KOWSKI, M. KULUS, 
A. ZAWADZKA-KRAJEWSKA, J. LANGE AND R. KOZIOEK 
Department of Pediatric Pneumonology, Allergology and Hematology, Warsaw Medical University, 
01-184 Warsaw, 1 Dzialdowska St., Poland 
During 1994-1998, 28 children, aged from 2 to 14 years, with bilateral or unilateral bronchiectases were hospitalized in our 
clinic due to acute respiratory infections. In all cases, serological and enzymatic tests, tissue culture were performed to detect 
viral infection. In 14 cases we obtained confirmation of parainfluenza virus type 3 infection, adenovirus infection in seven 
cases, and Coxackie Bs + adenovirus in seven cases. In 23 cases administered treatment was only symptomatic - fenspiryde. In 
five cases (age from 2 to 3 years) bacterial culture of bronchoalveolar lavage was positive, patients were treated with 
antibiotics according to antibiograms. 
Conclusions: In children with bronchiectases in autumn months exacerbations of the disease are usually due to viral 
infections. Usually, symptomatic treatment is sufficient for recovery (good response to fenspiryde). In case of bacterial 
superinfection there is a need of antibiotic therapy according to antibiogram. In all cases of bronchiectases, additional 
antiviral and antibacterial immunization is required. 
26. Detection of respiratory viruses in respiratory tract infections (RTI) of 
newborns/infants 
A. M. RABAGLIATI, L. FAMULARO AND R. PENNA” 
Central Laboratory Analysis of Pediatric “G Gaslini” Institute, Genova, *Laboratory of Clinic “Salus”, 
Alessandria, Italy 
We studied the possibility of detection of respiratory viruses (RV) in RTI of newborns/infants. 
Antigens of Respiratory Syncytial Virus (RSV), Adeno-V(AV), Influenza A-V(IAV) and B-V(IBV) and Parainfluenzal,2,3- 
V(PiV) of 433 specimens of fresh respiratory secretions from patients (2m - 5y old) with pulmonary/bronchial infections were 
examined by microscopic IF assay. Two methods were used: a) IF on epithelial cells of specimens, b) IF after culture of 
specimens on MRC -5 and/or Hep -2 cells. On the whole, 1674 investigations were carried out with one or both methods: 428 
vs RSV, 282 vs AV, 370 vs IAVIIBV and 594 vs PiV. 
Positive specimens included 15.9% (81/510) of nasopharyngeal aspirates, 6.9% (211305) of nasal washes, 5.3% (37/695) of 
brushings, 3.1% (3/97) of bronchoalveolar lavages, 3.0% (l/33) of nasal swabs and 2.9% (1134) of other. RSV was found in 
29.7% (127/428) of investigations, ADV in 2.5% (71282) IAV/IBV in 1.1% (4/370) and PiV in 1% (6/594). 
Our data show that nasopharyngeal aspirate is the most suitable specimen to detect RV in RTI.These further support that 
the management of RTI in newborns/infants, especially those “at risk” or with bronchiolitis, should undergo virologic 
investigations by IF as an helpful diagnostic tool. 
27. Pharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae type 
b and antibiotic resistance in HIV-positive children in Nairobi, Kenya 
A. RIDDELL, M. OTSYULA, A. SEFTON AND R. BOOY 
Department of Child Health, St. Bartholomew’s and the Royal London Medical and Dental Schools, 
Queen Mary Westjield College, University of London, UK. 
Background: Antibiotic resistance in pneumococci has emerged as an increasingly difficult clinical problem. Resistance patterns 
vary around the world, tending to be relatively low in the U.K. and U.S.A. and high in Africa and some parts of Europe. 
Within a particular geographical region one may expect to see different resistance patterns and bacterial carriage depending on 
the extent of antibiotic exposure. Other factors such as coexistent disease, which influences immune status, may be important. 
Objectives: To assess pharyngeal carriage of Streptococcus pneumoniae (pneumococcui) and Haemophilus inftuenzae type b 
(Hib) in HIV-positive children. 
Methods; Pharyngeal swabs were taken from 50 HIV-positive children (age range between 9 months to 13 years) in Nairobi, 
Kenya in July 1999. Two sets of swabs were taken from each child. One set was cultured locally and the other at the Royal 
London Hospital. Information regarding symptoms and current antibiotic treatment was documented. Local ethics approval 
was given. 
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Results: Seven children had pneumococci isolated from their throat swabs. The isolates were universally resistant to 
trimethoprim, co-trimoxazole and sulphamethoxazole, 57% were resistant to tetracycline, 14% were resistant to erythromycin 
and 28% had intermediate sensitivity to ampicillin and cefuroxime. Twelve of the children had Hib isolated from their throat 
swabs. Of these 50% were resistant to trimethoprim with the remainder being of intermediate sensitivity and only one being 
sensitive. Of the Hib strains isolated 8% were resistant to ampicillin, co-amoxiclav, cefuroxime, ciprofloxacin and tetracycline. 
Four children were carrying both pneumococci and Hib. 
Conclusions: In this group of children cotrimoxazole prophylaxis is prescribed to be given on three consecutive days of the 
week. We have demonstrated that isolates of Hib and pneumococci have considerable resistance to trimethoprim and 
sulphamethoxazole. The pneumococcal isolates also showed multiple resistance to the commonly used and available 
antibiotics for lower respiratory tract infections in resource poor countries. Widespread use of antibiotics within the 
orphanage may have given rise to resistance. This may be avoided by not using prophylaxis and/or limiting antibiotic 
treatment for uncomplicated upper respiratory tract infections. 
28. Comparative clinical study of the tolerability and efficacy of two dosage 
azithromycin and claritromycin in the treatment of community acquired pneumonia in 
adults (progress report) 
S. SCHOENWALD*, I. KUZMAN”, I? SESARTIC, J. VUKOVIC AND J. CULIG 
*University Hospital of Infectious Diseases; Pliva d.d. Pharmaceutical Operations; Zagreb, Croatia 
Community acquired pneumonia (CAP) is a serious disease frequently treated empirically, which requires the selection of an 
antibiotic that covers all common pathogens and achieves good pulmonary concentrations. A total of 180 hospitalised adult 
patients with CAP will be included into the study according to a randomisation list. Patients are divided into three treatments 
group. Dosage regimens are shown in the table below: 
TABLE 
Treatment Azithromycin Azithromycin Claritromycin 
Daily dose 
Days of administration 
1 X 1500 mg 1X500 mg 2X250 mg 
1 3 10 
Control clinical examinations are performed 24 h, 48 h, 72 h, lo-14 days and 4 weeks after the initiation of treatment. 
Clinical and microbiological response rates, clinically significant abnormal laboratory values as well as the adverse event 
profile are followed. 
Preliminary results indicate that 3-day, once-daily course of azithromycin is clinically effective and well tolerated as a lo- 
day, twice-daily course of clarithromycin in the treatment of CAP: 
29. Invasive pulmonary aspergillosis with additional CMV infection at 4 years old boy 
J. ZIO KOWSKI, D. CHMIELEWSKA-SZEWCZYK, J. PERADZY SKA, M. KULUS, U. DEMKOW”, 
J. LANGE, A. ZAWADZKA-KRAJEWSKA AND R. KOZIOEK 
Department of Pediatric Pneumonology, Allergology and Hematology, Warsaw Medical University. 01-184 
Warsaw, I Dzialdowska St., Poland; *Institute of Tuberculosis and Lung Diseases, Warsaw, Poland 
A 4 year old, Caucasian boy was admitted to the hospital with primary diagnosis of pulmonary tuberculosis. On the basis of 
bronchoalveolar lavage culture and mycelium presence in pulmonary biopsy, the final diagnosis of invasive pulmonary 
aspergillosis was set. Additionally, in the 8th month of the disease duration, CMV infection was detected. Patient was treated 
with amfotericine B, 5-fluorocytozine and itraconazolum. Despite a full recovery obtained, in the follow up period pulmonary 
fibrosis, as a complication after fungal infection was detected. During 4 years of follow up, patient did not suffer from 
infections of respiratory system. Periodically performed immunological laboratory tests were negative. After recovery patient 
was vaccinated with Pneumo 23 and Vaxigrip (Pasteur-Merieux) vaccines. 
